Condition

Polyarticular Juvenile Idiopathic Arthritis

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions1

Lead sponsors shown1

Clinical trials

1 shown

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSNCT04018599 · 2019-07-15

COMPLETED

Common interventions

40 mg MSB11022DRUG1

Leading sponsors

Fresenius Kabi SwissBioSim GmbH1

Trial status mix

COMPLETED1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.